MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

2/1/24 5:10:08 AM ET

$AFL

$ARQT

$ING

$MXL

Accident &Health Insurance

Finance

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $AFL alert in real time by email

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 90 points on Thursday.

Shares of MaxLinear, Inc. (NYSE:MXL) shares fell sharply during Thursday’s pre-market trading after reporting fourth-quarter results.

MaxLinear posted adjusted earnings of 1 cent per share, compared to market estimates of 1 cent per share. The company’s quarterly sales came in at $125.35 million versus expectations of $125.11 million, according to data from Benzinga Pro.

MaxLinear shares dipped 13.4% to $18.00 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

ING Groep N.V. (NYSE:ING) shares declined 8.7% to $12.97 in pre-market trading following fourth-quarter results.
Nyxoah S.A. (NASDAQ:NYXH) shares tumbled 8.4% to $9.91 in pre-market trading after jumping around 33% on Wednesday.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shares fell 8% to $5.40 in pre-market trading. Steven Cohen reported a 5.2% passive stake in Arcutis Biotherapeutics in 13G Filing.
Rocket Lab USA, Inc. (NASDAQ:RKLB) shares declined 6.8% to $4.52 in pre-market trading after the company announced a proposed offering of $275 million convertible senior notes.
Wolfspeed, Inc. (NYSE:WOLF) shares fell 6.5% to $30.45 in pre-market trading following the company's second-quarter earnings.
ZoomInfo Technologies Inc. (NASDAQ:ZI) fell 3.1% to $15.55 in pre-market trading. B of A Securities recently upgraded the stock from Neutral to Buy and raised its price target from $20 to $25.
Aflac Incorporated (NYSE:AFL) shares declined 2.1% to $82.55 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
Sanofi (NASDAQ:SNY) fell 2% to $48.88 in pre-market trading after the company posted fourth-quarter results and named François-Xavier Roger as Chief Financial Officer.

Now Read This: Apple, Honeywell International And 3 Stocks To Watch Heading Into Thursday

Don’t forget to check out our premarket coverage here

Get the next $AFL alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
ZoomInfo Technologies Inc $ZI	11/19/2024	$10.30	Sector Perform	Scotiabank
ING Group N.V. $ING	10/22/2024		Overweight → Equal Weight	Barclays
ING Group N.V. $ING	10/9/2024		Buy → Hold	Deutsche Bank
AFLAC Incorporated $AFL	10/9/2024	$102.00	Hold	TD Cowen
Wolfspeed Inc. $WOLF	10/3/2024	$17.00 → $8.00	Neutral → Underperform	Mizuho
MaxLinear Inc. $MXL	10/1/2024	$15.00	Positive → Neutral	Susquehanna
Rocket Lab USA Inc. $RKLB	9/12/2024		Mkt Perform	JMP Securities
AFLAC Incorporated $AFL	9/5/2024	$96.00	Underweight	Barclays

More analyst ratings

MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Chat with this insight

Recent Analyst Ratings for $AFL$ARQT$ING$MXL

$AFL$ARQT$ING$MXL Press Releases

Fastest customizable press release news feed in the world

Aflac Incorporated to Webcast 2024 Financial Analysts Briefing

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

ZoomInfo uses Telmai to automate data quality at scale, over billions of data records and across multiple cloud sources

$AFL$ARQT$ING$MXL Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Arcutis Biotherapeutics Inc.

SEC Form SC 13G filed by Wolfspeed Inc.

Amendment: SEC Form SC 13G/A filed by ZoomInfo Technologies Inc

$AFL$ARQT$ING$MXL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Olson Jon A sold $1,034,315 worth of shares (50,000 units at $20.69), decreasing direct ownership by 10% to 432,275 units (SEC Form 4)

Director Jackson Darren R bought $249,999 worth of shares (36,975 units at $6.76), increasing direct ownership by 75% to 85,996 units (SEC Form 4)

Chairman of the Board Werner Thomas H bought $244,785 worth of shares (37,500 units at $6.53), increasing direct ownership by 53% to 108,549 units (SEC Form 4)

$AFL$ARQT$ING$MXL Financials

Live finance-specific insights

Aflac Incorporated to Webcast 2024 Financial Analysts Briefing

Rocket Lab Announces Third Quarter 2024 Financial Results, Posts 55% Year-on-Year Growth and Guides to Record Revenue in Q4

Wolfspeed Reports Financial Results for the First Quarter of Fiscal Year 2025

$AFL$ARQT$ING$MXL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$AFL$ARQT$ING$MXL Market Insights

Live Market Insights

$AFL$ARQT$ING$MXL SEC Filings

$AFL$ARQT$ING$MXL FDA approvals

Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

Director Jackson Darren R bought $249,999 worth of shares (36,975 units at $6.76), increasing direct ownership by 75% to 85,996 units (SEC Form 4)

Chairman of the Board Werner Thomas H bought $244,785 worth of shares (37,500 units at $6.53), increasing direct ownership by 53% to 108,549 units (SEC Form 4)

Director Smith Stacy J bought $195,372 worth of shares (30,376 units at $6.43), increasing direct ownership by 132% to 53,357 units (SEC Form 4)

This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Market-Moving News for July 25th

Wolfspeed Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form 6-K filed by Nyxoah SA

SEC Form DEFA14A filed by Wolfspeed Inc.

FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

FDA Approval for ADLYXIN issued to SANOFI-AVENTIS US

FDA Approval for SARCLISA issued to SANOFI AVENTIS US

$AFL$ARQT$ING$MXL Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Scotiabank initiated coverage on ZoomInfo with a new price target

ING Groep downgraded by Barclays

ING Groep downgraded by Deutsche Bank

$AFL$ARQT$ING$MXL Leadership Updates

Live Leadership Updates

Wolfspeed Announces Leadership Transition

Aflac hires JR Shamley as senior vice president, National Account Business Development and Growth Solutions

Nyxoah Appoints John Landry as Chief Financial Officer

Recent Analyst Ratings for
$AFL
$ARQT
$ING
$MXL

$AFL
$ARQT
$ING
$MXL
Press Releases

$AFL
$ARQT
$ING
$MXL
Large Ownership Changes

$AFL
$ARQT
$ING
$MXL
Insider Trading

$AFL
$ARQT
$ING
$MXL
Financials

$AFL
$ARQT
$ING
$MXL
Insider Purchases

$AFL
$ARQT
$ING
$MXL
Market Insights

$AFL
$ARQT
$ING
$MXL
SEC Filings

$AFL
$ARQT
$ING
$MXL
FDA approvals

$AFL
$ARQT
$ING
$MXL
Analyst Ratings

$AFL
$ARQT
$ING
$MXL
Leadership Updates